ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer's Disease.

Laura Trujillo-Estrada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.